21 May 2023
LML's Rebecca Brown Wins Prestigious Prize in International Law
Rebecca Brown, a PhD candidate and member of the Centre for Law, Medicine and Life Sciences (LML), has been awarded the 2023 Australian Yearbook of International Law (AYBIL) and Australian and New Zealand Society of International Law (ANZSIL) Student Paper Prize for her paper "Quarantine Island: Australia's Health Policy and its Construction of Int…
14 Apr 2023
Registration open for CeBIL Symposium 2023 - Intellectual Property & Biologics: Policy Challenges and Responses
Registration is now open for the CeBIL Annual Symposium 2023 - Intellectual Property & Biologics: Policy Challenges and Responses.Biologics include some of the most innovative and expensive drugs today. They also raise some of the more complex intellectual property (IP) strategies. Patents provide exclusivity in national markets for the molecules, …
21 Mar 2023
Commemorating Professor Bill Cornish at the CIPIL Spring Conference 2023
The Centre for Intellectual Property and Information Law (CIPIL) hosted its Annual Spring Conference on March 17, 2023, with the theme "Intellectual Property Rights as Allied Rights: Bill Cornish and the Making of Today’s Intellectual Property System" and LML’s Professor Kathy Liddell gave a talk entitled ‘The IP Family: Are Pharmaceutical Regulato…
20 Mar 2023
Baron de Lancey 2023
On 16th March 2023, the Centre for Law, Medicine and Life Sciences hosted the annual Baron de Lancey public lecture. This year’s speaker was Professor Emily Jackson, a Professor of Law at the London School of Economics. Professor Jackson delivered a talk entitled ‘Assisted Dying: Slippery Slopes and Unintended Consequences’. Professor Jackson discu…
23 Feb 2023
LML says farewell to Jacquelyn Veraldi
The Centre for Law, Medicine and Life Sciences (LML) is sad to say goodbye to Jacquelyn Veraldi who has been working as a Research Associate for LML in partnership with the Centre for Advanced Studies in Biomedical Innovation Law (CeBIL). Jacquelyn has contributed to research relating to competition law and the pharmaceutical sector. She was the re…
23 Jan 2023
LML welcomes Georgia Michell and Ashleigh Hamidzadeh
Ms Georgia Michell has joined the Centre for Law, Medicine and Life Sciences (LML) as a Project Coordinator to assist the Director and Deputy Director of LML, Professor Kathy Liddell and Dr Jeffrey Skopek, in achieving the objectives of the Centre. Georgia has a Bachelor of Social Science and a Bachelor of Laws from the University of Cape Town and …
5 Dec 2022
SSHRC SAFE AMR Workshop
On 1-2 December 2022, a kick-off meeting for the SSHRC Partnership Grant took place in Banff, Canada. This new multidisciplinary global governance partnership has come together to address the development of drug-resistant microbes that threaten health, food systems, and the environment. The workshop brought together the main partners of the grant t…
21 Oct 2022
Professor Timo Minssen joins LML as a Research Affiliate
The Centre for Law, Medicine and Life Sciences is delighted to welcome Prof. Timo Minssen (University of Copenhagen) as an Affiliate Member. The position of Affiliate covers researchers beyond the Faculty of Law who represent, participate in, or run, specific projects on behalf of LML.Prof. Minssen is Professor of Law at the University of Copenhage…
10 Oct 2022
Prof. Kathy Liddell co-authors mixed-method study on organizational decision making about Covid-19 asymptomatic testing in workplaces
Workplace health interventions can raise complex ethical issues, for example relating to privacy, equity, and unintended consequences. The UK government and some advisory bodies issued guidance on mass asymptomatic testing for COVID-19 during waves of the pandemic, but few resources have focused specifically on the ethical issues in workplace setti…
7 Oct 2022
Prof. Kathy Liddell Represents LML at International Workshop on Antimicrobial Resistance
From 5 – 6 October 2022, Prof. Kathy Liddell participated in the INAMRSS/CeBIL Copenhagen AMR Workshop: Solutions to AMR from the Social Sciences.This Workshop sought to bring together the international scholarly community – in particular those working in the social sciences – to establish a coherent evidence base to guide national and internationa…
12 Sep 2022
Dr John Liddicoat leads LML empirical study on the repurposing of generic drugs
Commentators claim that drug repositioning (i.e. developing new uses for authorised drugs) significantly slows when generics are authorised and, therefore, law reform is necessary to encourage more R&D.'Repositioning Generic Drugs: Empirical Findings and Policy Implications' empirically examines this claim by analysing records of clinical trials. I…
6 Jul 2022
Prof. Mateo Aboy co-authors patent landscape of quantum technologies
Recent technical breakthroughs underscore the potential of second generation quantum technologies, including quantum simulation, quantum sensing and metrology, quantum computation, and quantum communication. Patenting trends of such technologies are an indicator of the pace of innovation at the invention stage. Empirical studies looking at the real…
27 May 2022
Jinal Dadiya featured in Diversifying the Law: Postgraduates in Profile exhibition
Today, the Faculty of Law’s Equality, Diversity and Inclusivity (EDI) Committee launched its Diversifying the Law: Postgraduates in Profile exhibition. Funded by the University’s Diversity Fund, the aim of the project is to highlight and to encourage reflection on diversity and its relationship to the law—not only as academic subject matter or init…
20 Apr 2022
Dr Claire Fenton-Glynn publishes results of survey on international surrogacy arrangements
From 18 February to 30 April 2021, Cambridge Family Law conducted an online survey to shed light on the domestic and international surrogacy arena – why it is done, how it is done, and the issues that intended parents, surrogates, and governments alike must be aware of.In doing so, the survey sought to understand the experiences of those who had be…
13 Apr 2022
LML patent research team published on European patent protection for medical uses of known products and drug repurposing
Finding new therapeutic uses for existing medicines holds significant potential, since it is often faster to develop a drug for a new use if it is already known to be safe and well tolerated by the human body. Repurposing de-risked compounds with previously known therapeutic effects is also an attractive drug development strategy because it can pot…
